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Background: Recent years have seen unprecedented growth in international travel. 29 
Travellers are at high risk for acquiring infections while abroad and potentially bringing 30 
these infections back to their home country. There are many ways to mitigate this risk by 31 
seeking pre-travel advice (PTA), including receiving recommended vaccinations and 32 
chemoprophylaxis, however many travellers do not seek or adhere to PTA. We conducted 33 
a systematic review to further understand PTA-seeking behaviour with an ultimate aim to 34 
implement interventions that improve adherence to PTA and reduce morbidity and 35 
mortality in travellers.  36 
Methods: We conducted a systematic review of published medical literature selecting 37 
studies that examined reasons for not seeking PTA and non-adherence to PTA over the 38 
last ten years. 4,484 articles were screened of which 56 studies met our search criteria 39 
after full text review. 40 
Results: The major reason for not seeking or non-adherence to PTA was perceived low 41 
risk of infection while travelling. Side effects played a significant role for lack of 42 
adherence specific to malaria prophylaxis. 43 
Conclusions: These data may help clinicians and public health providers to better 44 
understand reasons for non-adherence to PTA and target interventions to improve 45 
travellers understanding of potential and modifiable risks. Additionally, we discuss 46 
specific recommendations to increase public health education that may enable travellers 47 






The number of travellers to international destinations continues to grow year after year 52 
(1). In 2018, there were over 1.4 billion international travellers and almost half of the 53 
destinations were to low and low-middle income countries (LMIC)  (1). This represents 54 
the ninth consecutive year of sustained travel growth since 2009 (1). Most travellers do 55 
not seek pre-travel advice (PTA), and those who do infrequently adhere to the PTA they 56 
receive. PTA may include several recommendations such as dietary advice, vaccinations, 57 
and chemoprophylaxis for infections such as malaria. This lack of adoption to PTA has 58 
been illustrated repeatedly in many settings, for example, in Canada, where only 15% of 59 
travellers visiting countries with a high burden of hepatitis A received vaccination for this 60 
infection (2), in the US, where only 46% of travellers to developing countries at Boston 61 
Logan International Airport had sought PTA (3), and in Australia, where only 31% of 62 
travellers to low-income countries sought PTA (4). Such low rates of obtaining PTA may 63 
increase morbidity from infectious diseases related to travel.  64 
 65 
Further, PTA may have broader public health implications; infected travellers may import 66 
disease back to their country of origin, and can place a large number of individuals at risk 67 
of infection (5). Illness while travelling is common; in 2016, Vilkman et al. reported that 68 
76% of travellers experienced illness while abroad, and 25% still had ongoing symptoms 69 
or new complaints within two days of returning home (6). Other studies have found 70 
similar results, with one study demonstrating 64% of American travellers reporting 71 
illness while travelling or after returning, and another finding 70% of Israeli travellers 72 




To date there have been several prospective studies examining access and adherence to 75 
PTA (6), but much of the literature is comprised of retrospective studies of patients 76 
seeking medical advice after they have returned with an illness (2, 4, 7, 8), or travellers 77 
departing from only a few specific countries or cities. As such, the current literature 78 
demonstrates a wide variability in the type of traveller and the rationale behind different 79 
rates of access and adherence to pre-travel recommendations. The goal of this systematic 80 
review is to consolidate current evidence to better understand reasons for individuals to 81 
not seek or adhere to PTA. A better understanding of these factors may allow for targeted 82 
interventions from both primary care providers and policy makers with the goal of 83 
reducing morbidity and mortality in travellers, and potentially decreasing the likelihood 84 
of importing new diseases to non-endemic settings (9). 85 
 86 
Methods 87 
A systematic review was performed to better understand factors that affect seeking and 88 
adhering to PTA. Reporting conformed to PRISMA (Preferred Reporting Items for 89 
Systematic Reviews and Meta-Analyses) guidelines (10). Ovid MEDLINE and Ovid 90 
EMBASE were searched for English-language articles published from 2007 to October 91 
2017 that matched keywords for travel, communicable diseases, and adherence (see 92 
Appendix 1 for specific search terms). The past 10 years was chosen to reflect more 93 
modern trends in travel (e.g. destinations and types of travellers) and PTA. The results 94 
were deduplicated, then reviewed by two reviewers (DK, AF) for inclusion, with 95 
disagreements resolved by a third reviewer (TM). Inclusion criteria included quantitative 96 
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observational studies of people travelling from a high-income country to a lower-income 97 
country (as defined by the World Economic Situation and Prospects) (11) with the 98 
intention of returning. Studies included those that investigated PTA, malaria 99 
chemoprophylaxis, vector avoidance, respiratory precautions, and other risk behaviours 100 
including dietary advice and safe sexual practices. Participants included business 101 
travellers, vacationers, people visiting friends and relatives (VFR), missionary workers, 102 
and the military, and excluded studies related to immigration or refugee migration.  103 
We excluded randomized trials (in which adherence is likely to be grossly 104 
overestimated), case reports and studies of routine childhood vaccination. Retrospective 105 
studies looking at populations exclusively presenting following illness were also 106 
excluded as these were likely biased towards lower compliance rates with seeking and 107 
adhering to pre-travel advice.  108 
 109 
Full-text review was performed by two reviewers (DK, AF), with data extraction for 110 
country of origin, destination country, type of travel (business, vacation, VFR, or 111 
military), whether PTA was sought, the sources of PTA (including primary care 112 
physicians, travel clinics, or other healthcare provider, and the internet), rates of PTA 113 
adherence, factors affecting PTA adherence, and reasons for non-adherence to PTA. The 114 
results were separated into pre-specified categories of PTA including malaria 115 
chemoprophylaxis, vector avoidance, respiratory precautions, and risk behaviours, though 116 
one study could be included within several categories. Within each category, the included 117 
studies were summarized in tables in order to highlight common themes. Given the 118 
heterogeneity of the studies, with respect to behaviour assessed, type of traveler, 119 
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The pre-specified search criteria identified 4,484 articles after removing duplicates, of 124 
which 56 were included in the review (Figure 1). 125 
 126 
Pre-Travel Advice: Our review was not designed to capture all articles related to the rates 127 
of seeking PTA, but instead to articles that examined factors associated with seeking PTA 128 
and the behaviours that influenced adherence. Review of the papers related to PTA is 129 
summarized in Table 1. Adherence rates varied across the studies, from as high as 92.4% 130 
of travellers receiving PTA (12)  to as low as only 32.4% (13).  131 
 132 
Sources of PTA varied between studies: primary care providers (PCP) were the most 133 
widely used resource, but other sources included travel specialists, travel agents, 134 
employers, books, religious leaders, pharmacists, friends and relatives, and the internet. 135 
One study (30) found that most travellers (68.3%) considered PCPs to be the most 136 
trustworthy source of PTA, but 34.7% and 27.3% respectively, believed television and 137 
the internet were reliable sources as well. Factors consistently associated with lower rates 138 
of adherence with seeking PTA from the studies included being foreign-born (relative to 139 
the country of departure), VFR travellers, business travellers, more frequent travellers, 140 
being male, and a shorter duration of travel. Additionally, travellers to destinations with 141 




Nine studies examined the reasons for not seeking PTA. While these results varied 144 
significantly in the way in which data was captured, all nine studies found that the 145 
majority of travellers did not seek PTA for several reasons, including that travellers did 146 
not perceive any risk during travel, already felt well-enough informed, or just did not 147 
consider seeking PTA. These perceptions accounted for 38.9% to 86.0% (17, 20) of 148 
traveller’s reasons for not seeking PTA. Three studies demonstrated that time limitations 149 
were an additional reason for not seeking PTA, ranging from 5.0% to 18.9% of travellers 150 
(3, 20, 26). Further studies demonstrated other reasons for not seeking PTA including 151 
perceiving oneself of already being up to date with vaccines (one study with 31.5% of its 152 
travellers (26)) and finally excessive cost (two studies with 5.0% and 7.2% of travellers 153 
(3, 26)).  154 
 155 
Pre-Travel Vaccination: There is high variability in vaccine adherence ranging between 156 
1.0% for rabies vaccination (31), to as high as 100.0% for meningococcal vaccination for 157 
Hajj pilgrims, where vaccination is mandatory for travel (18). Other mandatory vaccines 158 
including yellow fever vaccines had similarly high vaccination rates (32). Anthrax 159 
vaccination for many United States soldiers is mandatory but one study (33) found that 160 
overall there was only a 68.2% acceptance rate for the vaccine in UK soldiers where it is 161 
not mandatory, but strongly recommended. The two vaccinations with the lowest uptake 162 
despite a recommendation from a Travel Medicine specialist were Japanese Encephalitis 163 




Along with high variability due to the type of vaccine other factors that influenced 166 
adherence included type of PTA, with the highest rate of vaccination from travel 167 
specialist clinics (14, 15, 18, 24, 35) and the lowest from those who did not see a health 168 
care specialist before travel. Business travellers were also found to have a lower rate of 169 
vaccination in one study evaluating influenza vaccination (36), but a higher rate for 170 
meningococcal vaccine (12) and hepatitis B (37). Age and sex had differing effects with 171 
several studies showing improved adherence to vaccination in younger travellers (12, 15) 172 
and others showing improved adherence in older individuals (18, 21, 35, 36). Women 173 
were found to have a higher rate of vaccine adherence in two studies (38, 39) and men in 174 
one study (37). VFR travellers were found to have lower rates of vaccine adherence in 175 
two studies (26, 34).  176 
 177 
Our study identified 13 articles that discussed reasons driving decision making for 178 
vaccine acceptance. These are also summarized in Table 2.  The majority of reasons for 179 
low vaccine adherence related to a lack of perceived risk of acquiring the disease for 180 
which the recommended vaccine was intended to protect against. Specifically with the JE 181 
vaccine, a lack of awareness the vaccine may contribute to its lower rates of adherence 182 
(15). 183 
 184 
Malaria Chemoprophylaxis: The studies investigating adherence with malaria 185 
chemoprophylaxis (CP) are summarized in Table 3. There is a wide variation in malaria 186 
chemoprophylaxis adherence rates among different studies, ranging from 10.5% (42) to 187 
99.7% (43). Additionally, there is a wide range of CP choices recommended. Studies 188 
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encompassed many different types of travellers including military, business, missionaries 189 
VFR and tourists.  190 
 191 
Factors that were associated with either increased risk for poor acceptance of CP or 192 
adherence to CP after starting were pregnancy (44), long duration of travel (17, 35, 44, 193 
45, 46, 47), alcohol and smoking (48), experiencing side effects from CP (17, 49), VFR 194 
status (26, 29), business travellers (28, 29), younger age (26, 28, 50) and being male (26). 195 
Adherence was increased in those travelling to higher malaria risk countries (35, 42, 51), 196 
those with a higher perceived threat of acquiring malaria (17, 48, 50), missionaries or 197 
volunteers (42, 47), seeing a travel specialist for PTA (17, 28, 47, 52, 53) as well as peer 198 
reinforcement among the travellers (48).  199 
 200 
Anti-Vector Protective Measures (AVPM): While many papers examined adherence 201 
with AVPM, there were few that examined factors that influenced traveller adherence 202 
with these measures and none of the articles examined the reasons for lack of adherence. 203 
Those included as summarized in Appendix 1, Table 1. Adherence rates differed 204 
significantly throughout the studies based on the type of AVPM, the type of traveller, and 205 
importantly the way in which the study defined adherence. Some included any use of the 206 
intervention, some regular use and others required 100% adherence with the intervention. 207 
Adherence ranged from as low as 1.0% for bed nets and 4.0% for repellant use (57) to as 208 
high as 98.5% for air-conditioned rooms (58). Average rates of adherence for repellant 209 
use was 45.1%, 40.0% for long sleeves and pants and 35.3% for bed net use. Air 210 




Factors positively linked to increased adherence include travelling to areas of higher risk 213 
for vector-acquired illnesses (47, 59, 60), increased age (60), requirement from military 214 
command (61) and personal or family history of malaria infection (60). Only one study 215 
discussed any potential reasons for not adhering with AVPM finding that 29.9% of flight 216 
attendants or pilots did not use repellant due to concerns over toxicity of the product or 217 
for the smell of the product, while almost all (98.5%) used an air-conditioned room that 218 
was contracted directly from the airline company.  219 
 220 
Respiratory Precautions: Respiratory precautions are not routinely recommended for 221 
most travellers, however they are occasionally recommended for those travelling to mass 222 
gatherings such a pilgrimages. Three studies met inclusion criteria and discussed factors 223 
influencing adherence with respiratory precautions in travellers. All three examined Hajj 224 
pilgrims travelling to Saudi Arabia. Overall, adherence with hand hygiene was higher 225 
than with facemasks. Adherence was even lower for the suggested practices of social 226 
distancing and contact avoidance. These results are summarized in Appendix 1, Table 2 227 
(62, 63, 64).  228 
 229 
Risk Behaviors: Food, Water, Sex and Safety: Three studies (46, 65, 66) examined 230 
people’s adherence with food and water safety and explicitly evaluated factors 231 
influencing adherence to prevention of food and water-borne infections (Table 4). 232 
Adherence to food and water precautions was low for travellers with trip durations on the 233 
longer or shorter end of the spectrum. For example, in long-term travellers, precautions 234 
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tended to decrease further in those travelling for more than six months (65). Younger 235 
travellers (18-35 years old) were less likely to adhere to low-risk behaviours such as 236 
drinking bottled water, avoiding undercooked meats and other similar precautions (66). 237 
None of these studies explored reasons for lower adherence rates in specific traveller-238 
types (Table 4). 239 
 240 
Four studies (45, 46, 65, 66) examined the effect of travel on drug and alcohol use while 241 
travelling. Among included studies, men where more likely to report increased alcohol 242 
intake while traveling, while women reported increased smoking (Appendix 1, Table 2).  243 
 244 
Six studies (45, 46, 65, 66, 67, 68) examined sexual behaviors while travelling. Rates of 245 
new partners while travelling varied from 4.0% (65) to as high as 50.2% (45). There was 246 
variability in barrier protection (e.g. condom use), ranging from 50.0% (46) to 85.6% 247 
(67). Additionally, there was variability by country of origin, destination country, type of 248 
traveller, and duration of travel. Men were significantly more likely to report new sexual 249 
partner in two studies (45, 65). However, these studies both found that women were less 250 
likely to use condoms. Those who did not bring condoms were less likely to have new 251 
sexual partners, but more likely to not use condoms if they did (67). One study (68) found 252 
that 78.9% of sexual encounters took place after alcohol or drug use, and that men were 253 
more likely to have encounters with local partners. The study also found more condom 254 
use if travellers brought condoms (OR 5.4), read STI information (OR 3.3) and used 255 





There is a steady increase in international travel volumes with approximately half of 259 
travellers visiting low and middle-income countries. Individuals are regularly exposed to 260 
infectious diseases while travelling and may potentially transmit these infections to others 261 
upon their return home. Many of these infections are preventable through vaccination, 262 
chemoprophylaxis, or other measures. All of these are typically addressed at pre-travel 263 
medical consultations, yet most travellers do not seek PTA or adhere with recommended 264 
precautions. A deeper understanding of the reasons for failing to seek or adhere to PTA 265 
may enable better strategies to ensure traveler health and safety. 266 
 267 
Prior to conducting this review it was our belief that the major barriers to seeking and 268 
adhering to travel related recommendations would pertain to cost and inconvenience of 269 
access. Instead we found that, despite the wide range of domains examined (e.g. PTA, 270 
malaria CP, vaccines, AVPM etc.) and type of travelers examined (e.g. business, VFR, 271 
vacation, military etc.), a lack of perceived risk was the most highly linked to seeking and 272 
adhering to PTA. 273 
 274 
In order to be able to receive many of the subsequent interventions recommended for 275 
travel, travellers first need to seek PTA. Lack of perceived risk while travelling was the 276 
predominant reason for not seeking PTA, despite the fact that morbidity may be high 277 
when risk is perceived is low (2, 6, 7). Surprisingly cost was not a significant barrier to 278 




Vaccine adherence in the reviewed studies varied significantly, likely due to 281 
heterogeneity of the vaccine recommendations (e.g. some, like yellow fever, were 282 
mandatory for travel), but despite this heterogeneity, perceived risk remained the 283 
strongest predictor of vaccine uptake in virtually all of the studies. Cost and side effects 284 
did not significantly affect reported adherence to recommended vaccines. Once again 285 
perception of risk was found to not correlate with actual risk, as illustrated by one study 286 
(12) that found that only one third of travellers to Sub-Saharan Africa recognized a risk 287 
of meningitis when traveling.  288 
 289 
Of note there were particularly low rates of vaccine uptake for Japanese Encephalitis (JE) 290 
and rabies, with 11.3% (15) and 1% (31) respectively. This is despite the potential for 291 
severe outcomes with infection and high efficacy of vaccination. A recent study by 292 
Connor et al. (69) suggests a low perceived risk of JE may be driving this finding despite 293 
the changing epidemiology of this infection, with increasing risk compared to historical 294 
data. Marano et al. (70) also shows a low perceived risk driving low rabies vaccine 295 
uptake. Cost was noted in only 14% of travellers for not receiving rabies vaccination, 296 
despite HCP believing it accounts for 61% of the reason.  One recent study (71) 297 
specifically looking at last minute travellers (those obtaining PTA < 7 days prior to 298 
departure) showed that they were much more likely to list lack of time as the major 299 
reason for not obtaining vaccines that required multiple injections, such as JE (52% listed 300 
time as reason for lack of vaccination) and rabies (41% listed time as reason for lack of 301 
vaccination). This suggests that accelerated vaccines schedules for JE and rabies may 302 
have beneficial effects in vaccine uptake and that systems that improve earlier PTA 303 
 
 15 
consultation could also improve uptake of these vaccines.  304 
 305 
Unlike vaccinations, malaria CP adherence was affected primarily by side effects of the 306 
medications, especially with medications such as doxycycline and mefloquine (17, 18, 307 
54, 56) and in long-term travellers (44, 45, 46). Despite the larger role of side effects in 308 
adherence, lack of perceived risk and perceived high baseline knowledge of infectious 309 
threats continued to play the major role in lack of adherence with malaria CP. With 310 
respect to AVPM there was significant heterogeneity in the studies that limited 311 
comparison between them. However it was noted that most of the studies demonstrated a 312 
trend towards increased adherence in those travelling to higher risk countries suggesting 313 
that travellers were more likely to take precautions if they were at a higher risk. Other 314 
domains examined in this study, including respiratory precautions and risk behaviours 315 
(e.g. food, water and sexual safety), did not have sufficient information to draw 316 
meaningful conclusions as to the reasons for lack of adherence and relationship with risk 317 
perception.  318 
 319 
Improving travellers’ perception of risk to better reflect ones actual risk would better 320 
allow for individuals to make informed decisions, and likely would improve adherence 321 
with travel recommendations. Interventions should be targeted to help close this gap. One 322 
possible intervention includes using online tools. The majority of travellers book their 323 
trips through online booking websites (72) and this could allow focused interventions to 324 
improved risk perception. For example, after booking a flight on a travel website, 325 
automatic messages could provide accurate information about the potential risks in the 326 
 
 16 
destination country to allow travelers to make informed decisions about risk mitigation. 327 
 328 
PCPs were the most widely used resource for PTA, however travellers also sought other 329 
reliable (e.g. travel specialist) and less reliable (e.g. internet) resources as well. Travellers 330 
who sought PTA had significantly more accurate perceptions of risk (16, 28). This 331 
finding has potential implications to improve traveller health; for example, as it is unclear 332 
what the quality of PTA is from PCPs, strategies focused on training PCPs may improve 333 
the quality of PTA provided. PCPs could have access to additional training in PTA and 334 
access to vaccines to help facilitate pre-travel health assessments. Additionally, PCPs 335 
may have additional training to recognize when a timely referral to travel specialist is 336 
warranted should they not have the capacity to conduct the pre-travel assessment. An 337 
interesting and related finding is that all of the studies evaluating alcohol consumption 338 
and sexual behavior found that travellers increased their use of alcohol and had greater 339 
frequencies of higher-risk (e.g. condomless) sexual behavior, especially in men. Potential 340 
interventions from those providing PTA should include counseling to help mitigate these 341 
risks, and PCPs typically have experience in this realm.  342 
 343 
Large gaps were seen in traveller’s knowledge about risk pertaining to vaccine 344 
preventable illnesses. The source of PTA also was an important factor for adherence to 345 
recommended vaccinations, with travel clinics having the highest uptake of vaccination 346 
(14, 15, 18, 24, 35), suggesting that not only is obtaining PTA important, but the quality 347 
of PTA is also critical for risk mitigation. Further highlighting this is the observation that 348 
those who were better informed of malaria risks were more likely to adhere with malaria 349 
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CP (26, 47, 52, 73).  350 
 351 
There are several limitations to this study. Given the significant heterogeneity of study 352 
design, we could only qualitatively analyze data. There are also several subject areas with 353 
insufficient studies to drawn meaningful conclusions. Our paper also excluded studies 354 
that looked at only travellers who presented for medical attention after travelling. This 355 
was because these travellers had already become sick and so the samples were biased to 356 
those who would have been less likely to comply with recommendations. These studies, 357 
however, may still provide meaningful data if interpreted within a limited context. 358 
Overall this heterogeneity makes it more difficult to draw definitive conclusions but does 359 
allow broader applicability given that certain trends still emerge, namely the gap between 360 
travellers’ low perceived risk of acquiring an infection and the actual risk of acquiring an 361 
infection. This knowledge and perception gap appears to drive the lack of adherence 362 
across a wide range of domains including seeking PTA, accepting vaccines, and reliably 363 
using malaria CP or AVPM. This knowledge and perception gap is also well documented 364 
over a wide spectrum of travellers, including VFR, business travellers, military 365 
personnel, and humanitarian workers.  366 
 367 
A greater understanding of factors affecting adherence to pre-travel advice may help with 368 
the design of programs to ensure travellers obtain proper care prior to departure, with the 369 
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PCP, 29.7% TS, TA 
9.1%, Book 10.4%, 
Employer 2.8%  
VFR had higher rate of PCP (57.0% vs 35.2%). Lower rates if 
foreign born (OR 2.29), travelling alone (OR 1.91), < 14 d (OR 
3.14), vacation (OR 2.19). 55.6% not concerned, 32.2% didn’t 
think of it, 5.0% too expensive and 4.9% too inconvenient. 
14 Australia 415/843 
(49.2%) 
79.5% PCP, 4.2% 
TS, 19.2% internet, 
13.5% TA 
Age > 55 (OR 2), female (OR 1.75), not married (OR 1.81), 
resident of birth country (OR 2.03), travelling with others (OR 
2.56), length of stay > 2 weeks (OR 1.8) > 3 months (OR 2.63), 





56.0% HCP VFR less likely to see HCP (33.3% vs 60.0%), high-risk travellers 





71.2% PCP, 8.9% 
TS, 12.3% internet 
VFR less likely (p=0.046), backpackers were more likely to see 
TS (p=0.014) or internet (p=0.002) 
16 Netherlands 232/328 
(70.7%) 
83.4% company TS, 
17.0% external 
source 
Study of business travellers only.  Top reason for non-adherence 
was: 49.1% who “Knew what to do.” Those who saw company TS 
had more accurate risk perception.  
17 Germany  811/1001 
(81.0%) 
47.9% PCP, 22.1% 
TS, 9.3% public 
health 
offices, 6.4% FR, 
5.1% internet, 4.1% 
pharmacies, 4.2% 
TA 
Kenya 89.0%, Senegal 81.9%, and Thailand 70.2% sought PTA. 
Last minute travellers, and age <40 sought non-medical advices 
more often. Reasons for not seeking advice were that individuals 
considered themselves sufficiently informed (70.0%) or that they 
perceived no risk at their destination (16.0%). Did not differ with 
purpose of travel.  
18 Australia 236/356 
(66.3%) 
57.0% PCP, 23.9% 
TS, 12.1% specific 
website for Hajj, 
16.8% internet. 
235/356 Hajj travel 
leaders, 161/356 
from FR 
Being 34-49 most likely to get PTA (OR 2.5). 47.0% did not 
recognize the need for advice, 32.2% preferred to use other 
sources i.e. family and friends, 14.1% reliance on previous 
experience, 6.9% previous negative experience with PTA.  
19 Thailand 323/434 
(74.4%) 
64.8% PCP or TS, 
38.0% internet, 
26.3% FR, 26.0% 
Guidebook, 22.8% 
Pharmacist 
Study of backpackers only. Mean travel knowledge was much 
higher for those who received PTA from PCP or TS than for those 
who did not (p<0.001). 




28.2% TA, 17.1% 
FR, 14.5% tourist 
office, 5.0% TS, 
0.9% other 
physician 
18.9% said they were too busy, 38.9% said they already knew the 
health risks, 16.2% considered that there was no risk to their 
health, and a third (32.4%) stated that they were unaware of the 






50.1% PCP and 
20.5% TS, 18.8% 
VR.  
US born travellers more likely to use internet, and more common 
to seek pre-travel (OR 3.1). Non-VFR (OR 2.77), Caucasians 





93.3% TS or PCP 
and 6.7% other 
40.0% of Nigerians had professional PTA, compares to 22-23% of 
Ghana and Kenya. Nigerians travel more repeatedly.  
23 Germany 468/975 
(48.0%) 
66.5% PCP, 22.4% 
TS, 12.1% Other 
More frequent travellers were less likely to seek PTA (68.2% to 
35.0% from 0 to > 5 trips). Odds ratio of carrying SBET: Other 
1.7, PCP 2.65, TS 7.83. 
24 Multiple 16904/19817 
(85.3%) 




78.1% in Canada, 57.9% Sweden from HCP. Vaccination rate 
from TS was 80.2%, HCPs was 67.3%, from non-HCP was 52.3% 
and no PTA was 31.0%.  
25 Australia 168/503 
(33.4%) 
87.8% PCP, 12.2% 
TS 
More likely if visiting high Hep A endemic country, longer trip 
and less frequent travellers. Perceived lack of risk: 34.4% ‘safe 
country,’ 17.1% ‘uneventful last visit,’ 14.3% ‘no need,’ 8.1% 
‘others told was safe,’ 9.8% ‘staying with family’ and 2.4% 







78.2% PCP, 21.8% 
TS 
Less likely in VFR, South Asian ethnicity, males, younger age, 
non-US citizens, persons who had traveled to India in the previous 
5 years, and those with at least a college education. Reasons: 
58.5% did not think needed, 31.5% vaccines up to date, 12.9% 





47.7% PCP, 32.8% 
TS and 19.5% 
internet 
Lower adherence if male (OR 1.8), foreign born (OR 2), < 2 
weeks to trip (OR 4.8), duration of travel < 7 d (OR 7.9), > 2 trips 
per year (2.7). Reasons: 47.5% not aware of need, 34.5% already 
knew what to do. Cost not listed.  
28 Spain 886/1212 
(73.1%) 
81.5% HCP, 13.6% 
TA, 4.5% personally 
obtained 
Less likely if Age > 50, travelling to South America, business 
travellers (80.7% of vacation and 37.7% of business), previously 
visited (88.2% vs 33.3%). Much lower perceived risk if informed 
by TA vs HCP (50.4% vs 20.4%) 
13 Australia 269/829 
(32.4%) 
84.4% PCP, 20.9% 
internet (such as 
government 
website), 5.5% TS, 
8.3% university 
Domestic students more likely than foreign students (38.2% vs 
12.4%, OR 4.4), Those 17-20 and those who had only travelled 
once in the past 12 months were more likely to see a HCP. VFR 
significantly less likely to see HCP than other sources (OR 0.5). 
Those that had sought PTA were more likely to be aware of 
vaccine for Hep A, B and measles. Overall risk perception low. 
Those who perceived high risk of Hep A were more likely to get 
PTA (OR 1.5).  
29 Netherlands 1994/3045 
(65.5%) 
For high risk: 27.8% 
TS, 11.8% PCP  
For low risk: 51.0% 
TS and 10.2% PCP 
High-risk destination 84.7% vs 59.6%. Elderly travellers less 
likely to get PTA, but overall KAP similar. Solo travellers less 
preparation, despite travelling to higher risk locations. Business 
travellers less frequently sought PTA (p<0.0005). VFR also less 
PTA (p=0.031 for high risk and p<0.0005 for low risk).  
TS = Travel Specialist, PCP = Primary Care Provider, TA = Travel Agent, FR = Friends 604 
and Relatives, PTA = Pre-travel advice, HCP = Health Care Providers, KAP = 605 
Knowledge, Attitudes and Practice 606 
NB: The numbers listed in column 4 will not always add up to 100% as some studies 607 
allowed participants to select more than one possible answer.  608 
  609 
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Reasons for not Adhering 
14 Australia 100/843 
(11.9%) 
Those who saw TS vc PCP 
were more likely to receive a 
pre-travel vaccine (58.3% vs 
20.3%). 
Not listed. 




Increased age (OR 1.03) and 
previous seasonal flu vaccine 
(OR 12.91) increased rate. 
Business negatively 
correlated (OR 0.39) 
37.1% vaccinated for business reasons, 20.9% 
vaccinated for age and 8.4% vaccinated for trip. No 
vaccine because felt not at risk (43.5%), missed 
recommendations by GP (19.2%) or did not see 
relevance of vaccine (23.0%). Other reasons 
included rare/never affected by influenza (5.7%), 
vaccine is not effective enough (4.5%) and bad 
experiences with vaccine/side-effects of vaccine 
(4.1%). Most travellers would consider vaccination if 
they would feel in bad general health (47.3%), 
followed by a recommendation of the family 
physician (37.7%) and travel to regions with known 
high risk of influenza (35.1%). 
15 United States 47/415 (11.3%) 
received JE 
vaccine 
Of those who would be high 
risk for JE, more likely to get 
if younger (mean age 34 vs 
41 among non-adherent). 
Higher rate if saw TS vs 
other HCP.  
60.2% were unaware of or had not been advised to 
receive the vaccine, 27.8% did not think they needed 
JE vaccine for their trip, 4.0% vaccines costs, 2.0% 
inadequate time and <1% concerns about possible 






Highest in those <35 years, 
backpackers, business 
travellers, and those who had 
previous visits to SSA. 
Increased adherence in those 
that knew meningitis was a 
risk of travelling to SSA.  
Traveller thought vaccine not needed (28.7%), GP 
advised vaccine not needed (24.8%), already 
vaccinated (24.2%), thought would take a risk 
(5.1%), TS advised not needed (3.2%), did not have 
time (2.5%), too expensive (2.5%).  






Not discussed: Only 
examining Hajj pilgrims 
Not aware of it (42.8%), reliance on natural 
immunity (6.25%), was not required (6.25%), didn’t 
think was important (5.35%), too busy (2.7%), 
remainder no answer (36.7%) 






Age > 40 increased 
vaccination (OR 2.5), 
university education also 
increased vaccination (OR 
3.4). PTA from PCP had 
positive effect on vaccination 
(OR 1.9) and tour group 
leader (OR 2.5). 
“I didn’t know about them” (56.3%), “I won’t get 
sick, I’m under Allah’s protection” (31.7%), “I don’t 
have chronic diseases” (30.1%), “I don’t worry about 
getting sick” (25.9%). Reasons for getting: “I don’t’ 
want to get sick” (73.0%), “tour group leader 
recommended” (64.4%), “my doctor advised me” 
(52.8%), “vaccine effective at protecting me” 
(44.8%). 
40 Netherlands 69.2% 
(202/292) 
Male (OR 1.98), from Ghana 
(OR 2.54), had health 
insurance (OR 2.48), VFR 
(OR 6.69). 
Short notice (18.9%), Expensive (16.7%), Never take 
(15.6%), get medication there (12.2%), up to date 
(10.0%), from there (8.9%), don’t get sick easily 
(7.8%) 
32 France 118/167 
(70.7%) 
VFR Children. Varied with 
vaccine proposed (YF 
100.0%, HepA 75.0%, 
Typhoid 75.0%, and BCG 
36.0%).  
Cost (36.0%), fear of adverse events (36.0%), 
neglect of vaccine (16.7%), perceived inefficacy of 
vaccine (11.1%) and lack of time before departure 
(5.5%) reasons for not adhering.  







Factors positively associated 
with HepB vaccination age, 
male, business (OR 16.9) or 
accompanying family (OR 
7), travelling to Asia (OR 
3.3), duration of travel > 1 
month (OR 20.4), patient’s 
company paid for vaccine 
(OR 21.5) 
Did not discuss. 
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Females more likely to get 
vaccinated. Receiving 
previous influenza vaccines 
increased the likelihood of 
receiving the vaccine (OR 
2.2). 87.9% from PCP, 5.0% 
from hospitals, 4.1% from 
workplace and 3.2% from 
others including TS.  
*Reliance on natural immunity (33.3% vs 25.7%), 
believing they rarely get influenza (17.9% vs 
29.1%), too busy (13.0% vs 17.1%), not aware of 
vaccine (12.2% vs 0.0%), do not like injections 
(8.3% vs 0.0%), fear of SEs (7.1% vs 1.9%), belief it 
does not work (7.1% vs 5.2%), thought gives the flu 
(6.4% vs 4.6%), had to pay (6.0% vs 2.1%). Reasons 
for: recommended by tour leader (64.6%), flu is 
serious (33.5%), recommended by doctor (30.4%), 
recommended by friend (12.1%), protect family 
(10.2%), offered at workplace (9.1%), working with 
vulnerable people (7.3%), consider themselves at 
risk (3.7%), travel to Hajj (2.8%). 








KAP of rabies higher in 
males with university degree. 
VFR had significantly lower 
KAP 
Reasons for refusal of preventive vaccination were 
mainly low benefit/risk for rabies (55.0%), high cost 
(25.7%), and adverse vaccine reaction (8.2%). 




Married (OR 1.61), Age 50-
64 (OR 1.74), Age > 65 (OR 
3.8). Neither the country of 
birth nor the purpose of 
travel affected. 
Reported reasons for not being vaccinated included 
not thinking they needed the influenza vaccine 
(56.8%), fear of becoming ill from the vaccine 
(13.2%), fear of needles (7.2%), belief that the 
vaccine had no effect (5.3%), receipt of vaccine >1 
year earlier and not thinking they needed it again 
(4.0%), and not believing in vaccination (4.0%). 
Cost, access to health insurance and lack of time 
rarely mentioned.  
24 Multiple 11660/19817 
(58.8%) 
HCP PTA: 9328/13857 
(67.3%), non-HCP PTA: 
1616/3047 (53.0%), no PTA: 
716/2334 (30.7%). Volunteer 
work had highest rates of 
seeking PTA and highest 
rates of adherence with 
vaccination.  
Lack of information (63.3%), cost (11.8%), safety 
(11.8%), lack of time, require reminder (3.1%), other 
(35.4%). Partial adherence: lack of information 
(36.3%), lack of time (27.8%) and need for 
reminders (24.3%). 







travel vaccine  
Rabies, JE and 
meningococcal were most 
likely to be declines (83.1%, 
76.2% and 39.2% 
respectively). VFR and those 
with children < 5 were more 
likely to refuse (OR 2.21 and 
1.64) 
Not discussed.   
39 Netherlands 517/2156 
(24.0%) 
Women (OR 1.28), second-
generation immigrants (OR 
1.4), older age, 2+ medical 
comorbidities (OR 1.8) were 
more likely to accept dTP 
vaccine.  
Not discussed.  




VFR 50.9% and 9.4% for 
HepA and Typhoid vs non-
VFR 68.8% and 36.6% 
respectively. More likely in 
those aged 18-39 as well.  
Not being advised by their healthcare provider 
(36%), not being aware of the vaccine (18%) and 
believing the vaccine unnecessary (21%). 
35 France 233/419 
(55.6%) 
Wide variability with type of 
vaccine (83.6% DTP, HepA 
49.7%, Typhoid 50.8%). 
Consulted a PCP (74.9% vs 
62.0%, OR 1.71). Retirees 
(83.8% vs 66.8%, OR 2.42) 
Unwillingness to be vaccinated against these 
diseases (68.4%), conflicting medical opinion 
(9.9%), not enough time (7.6%) and cost (4.1%) 




Individuals deployed later 
were more likely to refuse 
the vaccine (59.3% vs 
22.1%). 
Concern about SEs (88.1%), insufficient/unclear 
information about vaccine (72.1%), concern it was 
voluntary (50.9%), adverse publicity (50.9%), did 
not think there was a risk (50.2%), influence of 
colleagues (26.8%), influence of FR (15.3%), 




JE = Japanese Encephalitis, SE = Side Effects, SSA = Sub-Saharan Africa, MMR = 613 
measles, mumps and rubella, DTP = diphtheria, tetanus and polio. *Listed as 2011 614 
percentage compared to 2012 percentage. 615 










CP Factors Influencing 
Adherence 
Reasons for not 
Adhering 





100.0% A/P N/A – sample size who did not 
comply too small. Very 
heterogenous population of 
mostly male oil company 
workers.   
3/3 low perceived risk of malaria.  
51 United 
States 
88.5% (92/104) 100.0% A/P Travelling to SSA correlated 
with adherence (p=0.0063). 
Past malarious travel increased 
adherence (p=0.041). 
7/12 did not feel the medication 
was necessary, 2/12 were told by 
their tour guides that they did not 











64.6% (195/302) in daily CP 
group, 38.1% (16/42) in once 
weekly CP group 
39.2% GI upset, 31.8% 
forgetfulness, 22.3% low 
perception of risk.  










Higher adherence was seen 
with older age (p=0.02), 
satisfaction with counselling 
(p=0.02), perceived threat of 
mosquitoes (p=0.02) 
Not discussed.  
44 United 
Kingdom 
25.1% (82/327) 55.0% A/P, 
Doxy 19.9%, 
14.7% MFQ, 
3.7% CLQ  
Trend towards self-reported 
side effects and adherence. 
Travel longer than 1 year 
reduced adherence. Pregnancy 
reduced the adherence with 
malaria prophylaxis.  
68.7% cited concerns related to 
long-term side effects as the 
predominant reason for non-
adherence. 36.1% stated not 
reflecting the practicalities of 
long-term ex-patriot lifestyle.  








Increased adherence if advice 
from medical professional 
(PCP or TS), correct malaria 
risk perception, travel to Kenya 
vs Senegal.  
Reasons for not taking fear of 
adverse events (51.8%), previous 
experience of adverse events 
(25.2%), and “no risk perceived” 
(29.1%). Reasons for stopping 
were “absence of mosquitoes” 
(52.7%) and adverse events 
(21.6%) 
48 France 56.6% 
(684/1208) 
100.0% Doxy Increased with other AVPM, 
taking same time each day (OR 
2.37), peer to peer 
reinforcement (OR 1.38), 
higher perceived risk (OR 
1.65). Reduced with alcohol 
(OR 0.74) and smoking (OR 
0.6).   
Not discussed.  
45 Switzerland 35.5% 
(144/406) 
Not specified Linearly reduced adherence 
with increased mission time. 
Preference to treatment compared 
to prophylaxis, use of other 
protective measures and fear of 
side effects.  





More likely to stop if had GI 
side effects. More likely to stop 
if had Doxy compared to A/P.  
47.1% found it useless, 44.1% 









Use declines with longer 
duration at site (81.3% for < 3 
mo, 27% for 4-6 mo and 13.3% 
for > 7 mo).  
Side effects, low perceived risk 





57.6% (37/65) 55.3% Doxy, 
21.1% A/P, 
18.4% MFQ, 
2.6% CLQ  
Not discussed.  Reasons to stop once started: 
77.8% side effects, 11.1% forgot, 
22.2% though didn’t need.  





Higher rate in those to SSA 
(20.0%), missionaries and 
volunteers had higher rates at 
26.7% vs 6.6% in tourists. 
21.4% use if thought risk high 
Don’t know how to get (32.8%), 
low perceived risk (18.3%), side 
effects (14.4%), don’t like taking 
(10.5%), cost (7.2%), don’t work 
(5.0%).   
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compared to 1.8% if considered 
low risk.  






14.3% MFQ  
Business travellers were more 
likely to carry CP if saw 
company doctor.  
39.5% had not been advised to 
take, 22.5% judged is not 
necessary, 14.0% unsure, 7.1% 
had a dislike for all tablets.  












12.1% CLQ.   
Longer trip duration, single 
trips and trips undertaken for 
humanitarian reasons were 
associated with more 
appropriate CP use. Awareness 
that malaria was a serious 
disease (OR 2.03) and 
acquiring information from a 
physician (OR 3.01) improved 
adherence.  








3.1% MFQ.  
No significant difference based 
on sex, birth country, travel 
destination or duration, daily 
versus weekly CP and purpose 
of travel.   
Reasons for stopping: 50.3% 
forgetting to take, 30.6% side 
effects, 11.1% observing no 
mosquitoes 
Reasons for not taking: 50.3% 
told by someone CP unnecessary, 
28.6% thought low risk, 17.1% 
observed no mosquitoes, 17.1% 
cost.  
53 France 75.5% (80/106) 60.2% C/P, 
19.8% CLQ, 
14.9% MFQ  
Significantly higher use in TC 
group (86.1%) than TA group 
(60.0%). Higher adherence and 
more adequate medications. 







VFR significantly lower CP use 
(16.3% vs 39.4%, OR 0.41), 
Age < 40 (OR 0.71), Male (OR 
0.64), SEA decent (OR 0.26), 
US citizen (OR 3.2) 
VFR had lower perceived malaria 
risk.  
56 Italy 71.4% 
(4123/5773) 
99.1% MFQ 2002-2006 80.9% adherence, 
2007-2011 59.5% adherence.  
Forgetfulness (26.1%), Side 
effects (23.0%), Consider 
unnecessary (5.3%) 







Information received from 
travel agencies (87.6% vs 
50.0% informed by health care 
professionals, p<0.0000001, 
travel for business reasons 
(76.7% vs 63.6% travel for 
other reasons) (p<0.001), 
travellers younger than 30 
years or older than 39 years 
(70.3% vs 56.9% travellers 30 
– 39 y old) (p < 0.000002) 
23.4% stated they would obtain 
medication at their destination if 
became ill, 20.3% not obligatory, 
20.3% no recommendations 
made, 14.1% side effects, 14.1% 
only visiting urban areas.  
35 France 76.3% 
(219/287) 
Not discussed Travel destination of Kenya of 
Senegal increased adherence to 
86.2% vs 73.6%. Trips <15d 
had 85.0% adherence vs 67.6% 
for longer.  
20.6% side effects, 17.6% 
forgetting, 17.6% too many pills, 
13.3% no mosquitos seen, 11.8% 
tiredness, 10.3% do not like 
taking medication, 2.9% too 
expensive, 1.5% lack of pills.  







Business travellers and VFRs 
had significantly lower 
protection rates against malaria. 
Last minute much lower KAP. 
Increased protection rate over 
2002-2009.  
Not discussed.  
A/P - atovaquone and proguanil hydrochloride, Doxy = Doxycycline, MFQ = 620 
Mefloquine, PMQ = Primaquine, CLQ = Chloroquine, C/P = Chloroquine plus proguanil, 621 
NA = North America, TC = Travellers clinic, TA = Travel agent 622 
  623 
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Table 4: Studies examining adherence to recommendations to food and water safety, 624 










23.4% (156/667) reported > 3 
drinks/d, 26.0% (251/964) 
report increased drinking. 
Only 3/1010 reported never 
consuming a food item at risk 
for TD. 2.0% used illicit 
drugs. 4.0% had a new sexual 
partner while travelling and 
16.0% of these did not use 
condoms consistently.  
Women had lower rates of illicit drugs use 
and new sexual partners (OR 0.3 for each). 
Lower TDRB in those travelling alone or for 
shorter time. Alcohol had no effect on rates 
of TD but did increase the TDRB scores (OR 
1.5), new sexual partners (OR 6.5) and illicit 
drug use (OR 11.7). Did not affect the 
condom use. Women were more likely than 
men to inconsistently use condoms (OR 6.4)  





14% increased alcohol use, 
43.4% increased smoking and 
10.1% new start, 50.2% had 
new sexual partner, 35.5% had 
2 or 3 partners and 15.5% had 
> 4 partners. 64.0% always 
used condoms.  
Increased smoking if female, increased 
alcohol consumption if experiencing 
exhaustion. Longer missions increased the 
rates of new sexual encounters. Men more 
likely to report a sexual relationship (OR 
1.38). Women significantly less condom use. 
Living alone increased the risk for sexual 
risk behavior (OR 2.56). Older age inversely 
related to sexual risk behavior.  
Not discussed. 
46 United States 34.3% reported increased 
alcohol. 24.4% reported sexual 
encounters with a local partner 
(50.0% did not use a condom) 
50.0% only boiled or bottled 
water, 77.6% only well 
cooked meat, 67.7% avoided 
ice, 56.0% avoided raw 
vegetables, N = 42.  
52.1% adherence in those < 6 months and 
19.9% in those > 6 months.  
Not discussed.  










39.1% (456/1238) reported a 
new sexual partner, 14.4% 
(167/1238) report unsafe sex.   
Risk factors for increased unsafe sexual 
activity include male gender, age 20-24, 
being from the UK or Sweden, increased trip 
duration. Those who did not bring condoms 
were more likely to not use condoms, but 




5.0% (95/1907) had a new 
partner. 31.1% did not use a 
condom. 63.2% were local 
partner.  
78.9% of sexual encounters took place after 
alcohol or drugs. No difference in condom 
use between men and women, but men were 
more likely to have a local partner. More 
condom use if brought condoms (OR 5.4), 
reading STI information (OR 3.3) and using 
condoms with casual encounters at home.  
Not discussed 
66 Finland 5.0% did not use 
bottled/boiled water, 12.9% 
ate uncooked meat/fish, 78.8% 
ate salads, 24.1% had 3+ 
drinks/day, 14.4% did not 
always wash hands, 2.0% 
unprotected sex with local and 
71.1% walked barefoot. N = 
460 
Young adults (18-35 years) were more likely 
to eat uncooked meat/fish, to have freshwater 
contact, neglect hand washing, and not to 
shun salads or eating without utensils. Men 
consumed more alcohol than women (p  
<0.001). 
Not discussed. 
TD = Travellers Diarrhea, TDRB = Travellers Diarrhea Risk Behavior 627 
 628 
